Reoxcel

Reoxcels is a Spanish biotechnology company specializing in the field of redox biology to treat chronic liver diseases. Founded in 2021 as a spin-off from the University of Barcelona and IDIBAPS, the company develops small molecule therapies designed to restore cellular redox balance and mitigate oxidative stress. Their primary focus is on addressing liver fibrosis and cirrhosis, conditions with significant unmet medical needs and limited treatment options. By targeting mitochondrial dysfunction and reactive oxygen species, Reoxcels aims to halt or reverse disease progression in patients with advanced liver pathology. The company's research is grounded in decades of academic expertise in hepatology and oxidative signaling.